Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:CLVS
Tag: NASDAQ:CLVS
Analyst Activity – J P Morgan Chase & Co Reiterates Overweight...
ME Staff
-
August 1, 2017
0
Analyst Activity – Cann Reiterates Hold on Clovis Oncology (NASDAQ:CLVS)
ME Staff
-
July 31, 2017
0
Analyst Activity – Cann Reiterates Hold on Clovis Oncology (NASDAQ:CLVS)
ME Staff
-
July 31, 2017
0
Analyst Activity – Cann Reiterates Hold on Clovis Oncology (NASDAQ:CLVS)
ME Staff
-
July 31, 2017
0
Clovis Oncology, Inc. (NASDAQ:CLVS) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
July 7, 2017
0
Clovis Oncology, Inc. (NASDAQ:CLVS) Files An 8-K Entry into a Material...
ME Staff 8-k
-
June 26, 2017
0
TESARO Inc (NASDAQ:TSRO) Might Outperform Rivals with Zejula
-
June 23, 2017
0
Here’s What Just Happened With Clovis Oncology, Inc. (NASDAQ:CLVS) and Rigel...
-
June 20, 2017
0
Clovis Oncology, Inc. (NASDAQ:CLVS) Files An 8-K Unregistered Sales of Equity...
ME Staff 8-k
-
June 19, 2017
0
Clovis Oncology, Inc. (NASDAQ:CLVS) Files An 8-K Submission of Matters to...
ME Staff 8-k
-
June 8, 2017
0
1
2
3
4
Page 3 of 4
